Fuse Science Gives Away 400 EnerJel™ Bottles to Honor David Ortiz
"Big Papi" Hits His 400th Home Run on July 4, 2012
MIAMI LAKES, Fla., July 5, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP), (www.fusescience.com) an innovative consumer products company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce today that they are honoring their partner David "Big Papi" Ortiz for hitting his 400th home run by giving away samples of EnerJel™ product to fans.
"We are so excited for our athlete partners as they continue to reach new milestones in their respective sports and know that Fuse Science has played a part in their success," said Adam Adler, Chief Business and Development Officer at Fuse Science. "Big Papi is having one of the best seasons of his career. We are so proud of his accomplishment and for David being part of our team. He joins the 48 other players in Major League Baseball history that have ever achieved this milestone in their careers."
"My goal everyday is to perform at the highest level, and Fuse products allow me to perform and recover faster," said David Ortiz. "It's all about winning for me and I am excited to be part of the winning team at Fuse Science."
To celebrate David's 400th home run, Fuse Science is giving away 400 EnerJel™ bottles at www.poweredbyfuse.com to the first 400 fans that sign up. Fans must use promo code "PAPI400" and there is a limit of one per person.
About Fuse Science Inc.
Fuse Science Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
For more information: |
To schedule an interview: |
Fuse Science, Inc. |
Gus DeQuesada |
Investor Relations |
Michelsen Advertising |
Direct: (305) 503-3873, Ext. 2 |
C-305-733-1410 / 786-488-7138 |
Email: [email protected] |
SOURCE Fuse Science Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article